I've actually wanted to comment on this for quite some time but I still haven't been able to adequately parse your recent posts. From many of the immunocompromised studies I've looked at, including some of the studies from PAXLOVID and Molnupiravir they note similar mutations occurring, such as the N501Y and the E484K mutation appearing.
Dec 10, 2022·edited Dec 10, 2022Liked by Brian Mowrey
Nice job, as usual, Brian.
I thought that you might enjoy this new study, that seems to demonstrate quite "surprisingly" that younger, less wealthy and healthier people who drive more get into more traffic accidents than older, more wealthy and less healthy people who drive less: https://www.amjmed.com/article/S0002-9343(22)00822-1/fulltext
The most interesting thing to me about this study was that the risk of COVID infection among the vaccinated was 4.1% while the risk of COVID infection among the unvaccinated was 3.5%.
It is also very interesting to me how the Canada Research Chair in Medical Decision Sciences, the Canadian Institutes of Health Research, the Graduate Diploma in Health Research at the University of Toronto, and the National Sciences & Engineering Research Council of Canada all somehow managed to come through with the funds to investigate the hypothesis that younger, less wealthy and healthier people who drive more get into more traffic accidents than older, more wealthy and less healthy people who drive less, but somehow never considered funding the exact same sort of study to investigate which populations use hospitals more for health conditions associated with potential adverse effects of vaccines.
Brian, the last several posts of yours were exceptionally interesting, but unfortunately I realized that I cannot evaluate their correctness due to not knowing enough. I try my best to follow each of them however.
Have you seen recent, and NOT so recent suggestions that the latest variant soup is driven by molnupiravir?
I've actually wanted to comment on this for quite some time but I still haven't been able to adequately parse your recent posts. From many of the immunocompromised studies I've looked at, including some of the studies from PAXLOVID and Molnupiravir they note similar mutations occurring, such as the N501Y and the E484K mutation appearing.
Nice job, as usual, Brian.
I thought that you might enjoy this new study, that seems to demonstrate quite "surprisingly" that younger, less wealthy and healthier people who drive more get into more traffic accidents than older, more wealthy and less healthy people who drive less: https://www.amjmed.com/article/S0002-9343(22)00822-1/fulltext
The most interesting thing to me about this study was that the risk of COVID infection among the vaccinated was 4.1% while the risk of COVID infection among the unvaccinated was 3.5%.
It is also very interesting to me how the Canada Research Chair in Medical Decision Sciences, the Canadian Institutes of Health Research, the Graduate Diploma in Health Research at the University of Toronto, and the National Sciences & Engineering Research Council of Canada all somehow managed to come through with the funds to investigate the hypothesis that younger, less wealthy and healthier people who drive more get into more traffic accidents than older, more wealthy and less healthy people who drive less, but somehow never considered funding the exact same sort of study to investigate which populations use hospitals more for health conditions associated with potential adverse effects of vaccines.
Cool, nice job detective. 🧐
Brian, the last several posts of yours were exceptionally interesting, but unfortunately I realized that I cannot evaluate their correctness due to not knowing enough. I try my best to follow each of them however.
Have you seen recent, and NOT so recent suggestions that the latest variant soup is driven by molnupiravir?